Calithera Biosciences (STU:2CB0) Accumulated Depreciation : €-3.34 Mil (As of Dec. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Calithera Biosciences Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Calithera Biosciences's quarterly accumulated depreciation stayed the same from Jun. 2022 (€0.00 Mil) to Sep. 2022 (€0.00 Mil) but then increased from Sep. 2022 (€0.00 Mil) to Dec. 2022 (€-3.34 Mil).

Calithera Biosciences's annual accumulated depreciation increased from Dec. 2020 (€-2.81 Mil) to Dec. 2021 (€-2.92 Mil) and increased from Dec. 2021 (€-2.92 Mil) to Dec. 2022 (€-3.34 Mil).

Calithera Biosciences Accumulated Depreciation Historical Data

The historical data trend for Calithera Biosciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calithera Biosciences Accumulated Depreciation Chart

Calithera Biosciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accumulated Depreciation

Get a 7-Day Free Trial

-2.41

-2.88

-2.81

-2.92

-3.34

Calithera Biosciences Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Accumulated Depreciation	Get a 7-Day Free Trial															-2.92	-	-	-	-3.34

Calithera Biosciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Calithera Biosciences Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Calithera Biosciences's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Calithera Biosciences (STU:2CB0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calithera Biosciences Inc (STU:2CB0) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080

Website

https://www.calithera.com

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the United States. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Calithera Biosciences (STU:2CB0) Headlines

No Headlines